Table 1.
103 Reciprocal end point titer* | IgG2a,c/IgG1 ratio | ||||||||
Strain | Vaccine | IgA | IgG1 | IgG2a† | IgG2b | IgG2c‡ | IgG3 | IgG2a/IgG1 | IgG2c/IgG1 |
BALB/c | 2P × 2§ | ND¶ | 102 | 1,005 | 26 | — | 4 | 9.85 | — |
2P/RBD# | ND | 102 | 1,600 | 64 | — | 6 | 15.69 | — | |
RBD/RBD‖ | ND | 102 | 16 | 2 | — | 0 | 0.16 | — | |
C57BL/6 | 2P × 2§ | ND | 16 | — | 102 | 409 | 4 | — | 25.56 |
2P/RBD# | ND | 26 | — | 102 | 1,005 | 6 | — | 39.24 | |
K18-hACE2 | 2P × 2§ | ND | 26 | — | 102 | 409 | 2 | — | 15.98 |
2P/RBD# | ND | 26 | — | 256 | 409 | 6 | — | 15.98 |
Mean of duplicates of pooled sera.
Gene not present in C57BL/6 and K18-hACE2 mice.
Gene not present in BALB/c mice.
The 2P followed by 2P.
ND, not detected.
The 2P followed by RBD protein.
RBD protein followed by RBD protein.